Special offer on comprehensive genetic cancer testing
Comprehensive genetic testing for cancer is an important step for people who want to know if they have genetic factors that may increase their risk of developing certain types of cancer. It can also provide valuable information for people with cancer and their families when used appropriately and under the supervision of a qualified medical professional.
The comprehensive genetic cancer screening package is currently available at a special price of SAR 1870 instead of SAR 2550, thus saving the customer SAR 680, equivalent to a discount of approximately 27%, according to the price shown at the time of writing.
The package price can also be divided into four installments via Tamara, at a value of 467.5 riyals per installment, according to the terms available on the application page, making the screening easier for individuals and families.
What is comprehensive genetic testing for cancer?
Comprehensive genetic screening for cancer is an analysis that looks for specific changes in genes that may be associated with an increased risk of developing certain types of cancer.
Body cells carry genes that contain the instructions necessary for normal growth and function. Certain changes in some genes can impair a cell's ability to repair damage or control division, potentially increasing the likelihood of it becoming a cancerous cell.
Some genetic changes can be inherited from a parent, in which case they may be passed down within the family. Other changes occur within specific cells during a person's lifetime and are not necessarily passed on to offspring.
Therefore, it is essential to know the type of examination, its purpose, and whether it is looking for inherited genetic predisposition or changes within the tumor tissue before making any medical decision.
What is the difference between hereditary cancer and non-hereditary cancer?
Most cancers are not caused by a single inherited genetic change; rather, multiple factors such as age, environment, lifestyle, smoking, exposure to certain substances, and hormonal factors all contribute to the problem.
Hereditary cancer occurs when a person inherits a change in a gene that increases their likelihood of developing one or more types of cancer.
Having a genetic variant does not necessarily mean that cancer will develop, but it may mean that the likelihood of developing it is higher compared to other people.
Detecting this change may help initiating follow-up at an earlier age, increasing the frequency of preventive check-ups, or choosing a different type of follow-up according to the doctor's recommendations.
Who are the people who might benefit from the package?
A comprehensive genetic cancer screening package may be beneficial for individuals with a personal or family history suggesting a possible genetic predisposition.
Screening may be considered if a family member has had cancer at a young age, or if several family members have had the same type of cancer or related types.
Screening may also be appropriate if a person has more than one independent tumor or if cancer has appeared in paired organs such as the breasts or kidneys.
Having a known gene change in a relative can be a clear reason to discuss testing with a doctor or genetic counselor.
The doctor may also recommend testing if certain types of tumors or characteristics within the tumor suggest a possible genetic cause.
Does everyone need genetic cancer testing?
Not everyone needs to undergo genetic testing for cancer.
The benefit of testing is greatest when there are indications in the medical or family history that support the possibility of an inherited variant.
Conducting the examination without a clear medical reason may lead to results that are difficult to interpret or information that does not change the follow-up plan.
Therefore, it is advisable to consult a geneticist, oncologist, or genetic counselor before ordering the package in order to determine its suitability and the type of analysis required.
What are the benefits of comprehensive genetic testing for cancer?
The test can help detect a genetic change that may explain why cancer recurs in the family.
The result may contribute to developing a suitable follow-up program for the individual, including starting some tests at an earlier age or repeating them more frequently depending on the gene and type of cancer.
The result can also help identify family members who may need to be tested; if a pathological change is detected in one person, their relatives may be able to undergo targeted testing for the same change.
The results may provide information useful in discussing certain preventive or reproductive options with specialist physicians.
The package provider states that the examination may help the doctor choose the most appropriate treatment for some cancer patients, but this depends on the type of change, the nature of the tumor, the type of sample, and the analysis used.
Does a positive result mean I have cancer?
A positive result does not necessarily mean that the person currently has cancer, nor does it mean that they will definitely develop it in the future.
The result may indicate the presence of a genetic variant that increases the likelihood of developing the condition compared to those without the variant.
The risk level varies from gene to gene and is also affected by age, sex, family history, lifestyle, and other factors.
After a positive result, a doctor or genetic counselor should be consulted to determine its meaning and develop a follow-up plan appropriate for the case.
Major treatment or surgical decisions should not be made based on the report alone without a comprehensive medical evaluation.
What does a negative result mean?
A negative result means that the test did not find any known changes within the genes and regions analyzed.
But this does not mean that the person will not get cancer or that they do not need regular checkups.
There may be changes that are not covered by the test or that the technology used cannot detect, and the increased risk may be due to non-genetic factors.
If there is a family history of cancer, the doctor may continue to recommend a special follow-up program even with a negative outcome.
A negative result is more pronounced when there is a known genetic variant within the family and the test proves that the person did not inherit this variant.
What is the variable whose meaning is uncertain?
The laboratory may detect a genetic change for which there is insufficient scientific information to determine whether it is pathogenic or benign.
This type of result is called an uncertainly significant variable.
This variable should not be treated as a definitive cause of cancer, nor should it be used alone to make major preventative decisions.
The classification of the variable may change in the future as new information and studies emerge; therefore, it is important to know whether the laboratory offers a service for reanalyzing results and updating the report.
Does genetic testing replace early detection tests?
Genetic testing does not replace recommended early detection screenings.
Appropriate testing based on age, sex, and medical history should continue even if the genetic result is negative.
Early detection methods include breast, colon, and cervical examinations, among others, according to the doctor's instructions and the patient's health condition.
Genetic testing helps assess some aspects of risk, but it does not directly detect the presence of a tumor and does not replace imaging, endoscopy, or clinical examination.
Can family members benefit from the result?
Yes, because inherited genetic variations may be present in more than one family member.
If a positive result is obtained, the genetic counselor may recommend testing some relatives to determine if they carry the same variant.
This does not mean that all family members need comprehensive testing; testing focused on the detected change may be more accurate and less expensive.
The specialist identifies family members who may benefit from the test based on the degree of kinship and the method of gene transmission.
Can the results be used in choosing a treatment?
Some genetic information may help the doctor determine appropriate treatment options for certain types of cancer.
However, a distinction must be made between examining inherited genetic changes and examining changes present within tumor tissue.
Treatment selection may require analysis of a tumor sample or molecular testing different from genetic predisposition testing.
Therefore, the package provider should be asked whether the analysis is designed to assess genetic predisposition, guide treatment, or both.
Treatment should not be changed or stopped based on a genetic result without consulting an oncologist.
How is genetic testing performed?
The method of conducting the test depends on the type of analysis used by the laboratory.
Some tests can be performed using a sample of blood, saliva, or a swab from inside the cheek, while some tests related to treatment require a sample of tumor tissue.
The sample is sent to the laboratory to extract the genetic material and analyze the required genes. Then, specialists review the detected changes and issue a report explaining the results.
Before completing the order, you must confirm the type of sample required, the method of collection, and the time it takes for the results to appear.
How long does it take for the results to appear?
The time it takes for results to appear varies depending on the number of genes, the technique used, and the need to confirm certain changes.
Some tests may take several weeks, while more complex analyses require a longer period.
The service provider can be asked about the expected duration and whether there will be a follow-up consultation after the report is issued.
Why is genetic counseling important?
Pre-screening genetic counseling helps review medical and family history and determine the likelihood of a hereditary cancer.
It also helps the person understand the potential outcomes and what they could mean for him and his family members.
After the report is issued, the consultant explains the meaning of the result, the next steps, and whether the person needs a confirmatory test, follow-up, or a relative's test.
Consultation reduces the risk of misunderstanding the outcome or experiencing unnecessary anxiety.
Important questions before ordering the package
It is important to know the names of the genes included in the test and the types of cancer associated with them.
It is important to ask about the type of sample, the technique used, and the ability of the analysis to detect different types of genetic changes.
It should be confirmed whether the price includes genetic counseling before and after the test, and whether a positive result requires confirmatory testing.
It is also advisable to know the policy for reanalyzing variants of uncertain significance and how to protect, store, and share the sample and genetic information.
Special Offer Details
The comprehensive genetic cancer screening package is available for SAR 1870 instead of SAR 2550, according to the price shown at the time of writing.
The savings amount to 680 Saudi Riyals, which represents a discount of approximately 27 percent.
It is also possible to divide the order value into four installments through Tamara, at a value of 467.5 riyals per installment, according to the available terms and conditions.
Prices, offer duration, and payment methods may change, so please check the package page and confirm the final price before completing your order.
Comprehensive genetic testing for cancer helps assess certain genetic factors that may be associated with an increased risk of developing cancer.
The package may be beneficial for those with a strong personal or family history of cancer, an early-life injury, or a known genetic mutation within the family.
The special offer provides an opportunity to get the package for 1870 Saudi Riyals instead of 2550 Saudi Riyals, saving 680 Saudi Riyals.
Choosing a test and interpreting its results remains a medical step that requires consultation with a specialist, because a positive result does not necessarily mean infection, and a negative result does not rule out all risks.
The information provided is for informational purposes only and does not replace consultation with a qualified physician or genetic counselor.